Open access
102
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function
Marie T Borin1 Department of Clinical and Translational Pharmacology, Theravance Biopharma US, Inc., South San Francisco, CA, USA
https://orcid.org/0000-0002-1561-4051
Arthur Lo2 Department of Drug Metabolism and Pharmacokinetics, Theravance Biopharma US, Inc., South San Francisco, CA, USA
https://orcid.org/0000-0001-7474-1328
Chris N Barnes3 Department of Biostatistics, Theravance Biopharma US, Inc., South San Francisco, CA, USA
, Srikanth Pendyala4 Department of Clinical Development, Inflammation and Immunology, Theravance Biopharma US, Inc., South San Francisco, CA, USA
& David L Bourdet2 Department of Drug Metabolism and Pharmacokinetics, Theravance Biopharma US, Inc., South San Francisco, CA, USACorrespondence[email protected]
Pages 2305-2318
|
Published online: 08 Oct 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.